Search

Your search keyword '"Cusinato, S"' showing total 64 results

Search Constraints

Start Over You searched for: Author "Cusinato, S" Remove constraint Author: "Cusinato, S"
64 results on '"Cusinato, S"'

Search Results

1. Evidence from the large VALIGA cohort validates the subclassification of focal segmental glomerulosclerosis in IgA nephropathy

2. Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy

3. Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy

4. Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool

5. Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy

6. Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update

7. Risk factors and action thresholds for the novel coronavirus pandemic. Insights from the Italian Society of Nephrology COVID-19 Survey

8. Quantifying duration of proteinuria remission and association with clinical outcome in IgA nephropathy

9. Quantifying duration of proteinuria remission and association with clinical outcome in IgA nephropathy

10. POS-510 Analysis and monitoring of the spread of SARS-COV-2 infection among patients of Nephrology-Dialysis Units in Piedmont and Valle d’Aosta

11. First considerations on the SARS-CoV-2 epidemic in the Dialysis Units of Piedmont and Aosta Valley, Northern Italy

12. Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool

13. Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: Evidence from the VALidation of IGA study cohort

14. Defective gene expression of the membrane complement inhibitor CD46 in patients with progressive immunoglobulin A nephropathy

15. Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: Evidence from the VALidation of IGA study cohort

16. Evaluating a New International Risk-Prediction Tool in IgA Nephropathy

17. Evaluating a New International Risk-Prediction Tool in IgA Nephropathy

18. Evaluating a New International Risk-Prediction Tool in IgA Nephropathy

19. AISF position paper on HCV in immunocompromised patients

21. Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy

22. Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort

23. Tonsillectomy in a European Cohort of 1, 147 Patients with IgA Nephropathy

24. Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy

26. Evidence from the large VALIGA cohort validates the subclassification of focal segmental glomerulosclerosis in IgA nephropathy

27. Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy

28. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments

29. IGA NEPHROPATHY

31. The MEST score provides earlier risk prediction in lgA nephropathy

32. AISF position paper on HCV in immunocompromised patients

33. Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy

34. Eco-dialysis in Italy: where are we? National survey on the eco-sustainability of dialysis across Italian dialysis centers.

35. Increase of continuous treatments and regional citrate anticoagulation during renal replacement therapy in the ICUs of the North-West of Italy from 2007 to 2015.

36. Transcriptomic profile comparison of monocytes from rheumatoid arthritis patients in treatment with methotrexate, anti-TNFa, abatacept or tocilizumab.

37. Citrate high volume on-line hemodiafiltration modulates serum Interleukin-6 and Klotho levels: the multicenter randomized controlled study "Hephaestus".

39. The switch from proteasome to immunoproteasome is increased in circulating cells of patients with fast progressive immunoglobulin A nephropathy and associated with defective CD46 expression.

40. Renal involvement in sarcoidosis: histological patterns and prognosis, an Italian survey.

41. Defective gene expression of the membrane complement inhibitor CD46 in patients with progressive immunoglobulin A nephropathy.

42. Erratum to: Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.

43. Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.

44. Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy.

45. Can tonsillectomy modify the innate and adaptive immunity pathways involved in IgA nephropathy?

46. [HFR vs HDF-ON line: plasmatic amino acids loss evaluation].

47. [Safety in dialysis rooms. Biologic risks].

48. [Heart failure resistant to drug therapy. Nephrologic approach].

49. [Critical review of renal transplantation data from the Piedmontese Regional Dialysis and Transplantation Registry].

50. [Medical nephropathies: what has changed in 20 years].

Catalog

Books, media, physical & digital resources